Tectonic Therapeutic (NASDAQ:TECX) reported quarterly losses of $(0.93) per share which beat the analyst consensus estimate of $(1.22) by 23.77 percent. This is a 91.52 percent increase over losses of $(10.97) per share from the same period last year.